A detailed history of Grove Bank & Trust transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Grove Bank & Trust holds 1,000 shares of TEVA stock, worth $25,410. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 250 300.0%
Holding current value
$25,410
Previous $5,000 400.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 08, 2026

BUY
$18.95 - $25.83 $14,212 - $19,372
750 Added 300.0%
1,000 $25,000
Q3 2025

Oct 06, 2025

BUY
$15.38 - $20.2 $3,845 - $5,050
250 New
250 $5,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $28.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Grove Bank & Trust Portfolio

Follow Grove Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.